| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | Director | Ordinary Shares | 25,399 | $61,973 | $2.44 | 20 Feb 2026 | By Guangzhou Sino-Israel Biotech Fund |
| Silexion Therapeutics Corp | Director | Stock Option (right to buy ordinary shares) | 10,685 | $26,071 | $2.44 | 20 Feb 2026 | By Guangzhou Sino-Israel Biotech Fund |
| Brainsway Ltd. | Director | Ordinary Shares | 6,250 | 18 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BWAY | Brainsway Ltd. | 18 Mar 2026 | 0 | $0 | 3 | Director | 18 Mar 2026, 16:04 |
| SLXN | Silexion Therapeutics Corp | 20 Feb 2026 | 2 | $0 | 4 | Director | 23 Feb 2026, 16:06 |
| SLXN | Silexion Therapeutics Corp | 09 Feb 2025 | 2 | $0 | 4 | Director | 31 Dec 2025, 13:04 |
| SLXN | Biomotion Sciences | 15 Aug 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 15 Aug 2024, 19:38 |